SGX Pharmaceuticals, Inc. (NASDAQ:SGXP)
CAPS Rating:
A biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.
A biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.